Futura Medical plc (LON:FUM – Get Free Report) shares fell 12.7% on Wednesday . The stock traded as low as GBX 9.75 ($0.13) and last traded at GBX 10 ($0.13). 1,345,431 shares were traded during mid-day trading, an increase of 81% from the average session volume of 744,808 shares. The stock had previously closed at GBX 11.45 ($0.15).
Futura Medical Price Performance
The company’s 50-day simple moving average is GBX 18.38 and its two-hundred day simple moving average is GBX 28.85. The firm has a market capitalization of £31.48 million, a P/E ratio of -8.33 and a beta of 1.25.
Futura Medical Company Profile
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.
See Also
- Five stocks we like better than Futura Medical
- How to Use the MarketBeat Stock Screener
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- High Flyers: 3 Natural Gas Stocks for March 2022
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- How to Use the MarketBeat Excel Dividend Calculator
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.